High Times Presents: The U.S. Cannabis Cup

big pharma

Buzzkill: Scientists Create the O’Doul’s of Pot

While some high-minded scientists have been working diligently to bring to life more wickedly potent strains for the adventurous marijuana enthusiast to chief out to in his living room, others have been doing the exact opposite, by trying to find ways to prevent marijuana...

Drug Maker Secures Patent on THC and CBD as Cancer Treatment

A pharmaceutical company in the United Kingdom, specializing in the research and development of pot-based drugs, recently obtained early approval on a patent covering two specific cannabinoids found in marijuana to be used as treatment for brain cancer.

FDA: No to Medical Marijuana, Yes to “Super-Vicodin”

For years we have been told that raw, crude marijuana plants do not meet the Food & Drug Administration’s (FDA) guidelines for a safe, effective medicine.  Cannabis remains a Schedule I substance, deemed to have no medicinal value, is dangerously addictive,...

Pot Patients’ Preference: No Pills!

Plants or pills, which do you prefer? A recent worldwide study of medicinal cannabis patients makes their penchant clear. And the answer is hardly a surprise.

The Clinic: CBDs Kill Leukemia Cells

Last week, word leaked that GW Pharmaceuticals will supply the US government with cannabis-derived cannabidiol (CBD) for a special Investigative New Drug program, so at least 50 children with epilepsy can try the non-psychoactive marijuana-derived compound as a way to con...

Pages

Notice

Important notice for Seattle US Cannabis Cup attendees.
A company calling itself High Times Travel LLC (hightimestravel.com) has illegally infringed on the HIGH TIMES trademark to sell travel packages for the upcoming US Cup in Seattle.

This company is not affiliated with HIGH TIMES Magazine in any way. If you have purchased a travel package from High Times Travel LLC please contact HIGH TIMES immediately by emailing us at travelcomplaint@hightimes.com